|18.58||+0.92 / +5.21%|
Data as of 3:59pm ET
|18.58||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 27.50, with a high estimate of 35.00 and a low estimate of 15.00. The median estimate represents a +48.01% increase from the last price of 18.58.
The current consensus among 7 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.